Electrical stimulation to help paralyzed rats relearn rear leg movement; Covidien launches colorectal surgical stapler;

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> St. Jude Medical's ($STJ) stock is down about 24% from this time last year, but promising devices on the horizon could pay off big for the company, Barron's reports, and its shares could go up by 33% this year. Analysis

> On the heels of recalling its Roticulator line of staplers, Covidien ($COV) is launching the Endo GIA Radial Reload, a stapler designed for colorectal surgeries. Release

> A NeuroSigma-funded clinical trial at UCLA has generated promising initial results using external trigeminal nerve stimulation to treat post-traumatic stress disorder and major depression, along with drug therapy. Release

> Critical Diagnostics has hired Richard Hughes as its vice president of business development for Europe. He's a veteran industry executive who has worked for companies including Alere and British Biocell. Release

> Insight Genetics, a molecular diagnostics company, has licensed a lung cancer test to Chinese competitor, Kindstar Globalgene (Beijing) Technology. The deal is the first stem in a partnership designed to expand the availability of molecular diagnostics tests for cancer in China. Release

Biotech News

 @FierceBiotech: Forest Labs nabs rights to anti-MRSA antibiotic from Nabriva for $25M. Release | Follow @FierceBiotech

 @JohnCFierce: Now this you hardly ever see: BMS CEO throws down the gauntlet on Gilead, demands combo hep c study. Check it out. News | Follow @JohnCFierce

 @RyanMFierce: How many times did Marina change its name during lackluster run? I count at least 2 changes. | Follow @RyanMFierce

> Genzyme/Sanofi's oral MS drug Aubagio beats placebo in PhIII. More

> New chairman ramps up CEO search at struggling AZ. Article

> Marina Biotech hits a funding wall, shuts down RNAi ops. Story

> Bristol CEO says Gilead holding out on hep C tie-up. News

Pharma News

 @FiercePharma: PhRMA emails show behind-the-scenes dickering on industry's healthcare reform deal--WSJ. More | Follow @FiercePharma

> South Koreans eating up generic Viagra. Story

> Judge blocks run at Human Genome's 'poison pill' defense. More

> New AstraZeneca chairman looks for CEO. Article

> Takeda recruit refocuses marketing, R&D on emerging markets. More

> And Finally... Researchers in Switzerland were able to use electrical and chemical stimulation to help rats paralyzed by spinal cord injury learn to move their hind legs again, while wearing a rehabilitation device, MIT's Technology Review reports. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.